Inductible mouse models for oral cancer

口腔癌诱导小鼠模型

• 批准号: 7007722
• 负责人: CARLOS CAULIN
• 金额: $ 35.52万
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-01-13 至 2009-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7007722
• 关键词: biological signal transduction; biopsy; disease /disorder model; epidermal growth factor; flow cytometry; gene expression; gene induction /repression; gene mutation; genetic polymorphism; genetically modified animals; immunofluorescence technique; laboratory mouse; laser capture microdissection; model design /development; mouth neoplasms; neoplasm /cancer genetics; neoplastic transformation; oncogenes; p53 gene /protein; retinoblastoma; terminal nick end labeling; western blottings

DESCRIPTION (provided by applicant): Oral cancer is the seventh most common form of cancer and causes 8,000 deaths in the United States each year and 128,000 worldwide. Similar to other tumor types, it is widely accepted that the formation of oral cancer is a multi-step process that results from the accumulation of genetic alterations. The high frequency of genetic and epigenetic alterations found in certain genes strongly suggests a causal role in the development of oral cancer. Our long-term objective is to generate transgenic mice carrying inducible genetic alterations that closely mimic some of the most common mutations found in human cancer of the oral cavity. Although a large number of genetic alterations have been reported in oral cancer patients, three different molecular pathways seem to be the major targets of mutations, namely the p53, retinoblastoma (Rb) and Epidermal Growth Factor Receptor (EGFR) signaling pathways. Accordingly, the gene alterations most frequently found in oral cancer include EGFR overexpression, p53 mutations (such as the gain-of-function p53R175H) and inactivation of the INK4a/ARF locus, which functions at least in part as a negative regulator of the Rb pathway. We hypothesize that these mutations that have a high incidence in oral cancer patients play a causal role in the development of cancer of the oral cavity. To test this hypothesis we will use an inducible system to generate mouse models that exhibit p53 mutations, EGFR overexpression or inactivation of the INK4a/ARF locus only in the oral cavity. These models have several advantages over conventional transgenic/knockout models: the mutation can be targeted to a restricted area of the tissue and the moment of tumor initiation can be chosen. Therefore, they will closely mimic the sporadic focal accumulation of somatic mutations found in human tumors. These mouse models will be useful not only to better understand the molecular mechanisms of oral cancer development, but also as preclinical models for testing therapeutic agents for prevention and intervention of oral cancer.

描述(申请人提供)：口腔癌是第七种最常见的癌症，每年在美国造成8,000人死亡，在全球造成128,000人死亡。与其他类型的肿瘤相似，人们普遍认为口腔癌的形成是一个多步骤的过程，是基因改变积累的结果。在某些基因中发现的高频率的遗传和表观遗传改变强烈地表明在口腔癌的发展中起到了因果作用。我们的长期目标是产生携带可诱导的基因改变的转基因小鼠，这种改变与人类口腔癌中发现的一些最常见的突变非常相似。虽然在口腔癌患者中已有大量的基因改变的报道，但有三条不同的分子通路似乎是突变的主要靶点，即P53、视网膜母细胞瘤(Rb)和表皮生长因子受体(EGFR)信号通路。因此，在口腔癌中最常见的基因改变包括EGFR过度表达、p53突变(如功能获得p53R175H)和INK4a/ARF基因座失活，这些基因至少在一定程度上起到Rb途径的负调节作用。我们假设，这些在口腔癌患者中发病率较高的突变在口腔癌的发展中起到了因果作用。为了验证这一假设，我们将使用可诱导系统来生成仅在口腔中显示P53突变、EGFR过表达或INK4a/ARF基因失活的小鼠模型。与传统的转基因/基因敲除模型相比，这些模型有几个优点：突变可以针对组织的有限区域，并且可以选择肿瘤开始的时刻。因此，它们将密切模仿在人类肿瘤中发现的体细胞突变的零星局灶性积累。这些小鼠模型不仅有助于更好地了解口腔癌发生的分子机制，而且可以作为临床前模型来测试口腔癌预防和干预的治疗药物。